Fully resorbable sinus drug-eluting stent

A fully biodegradable magnesium-based drug-eluting stent that combines drug delivery with a metallic scaffold that gradually resorbs, restoring natural vessel function.

Bioresorbable drug-eluting stent system designed for peripheral vascular intervention in patients with stenotic or occluded peripheral arteries. The stent gradually resorbs while delivering therapeutic agents to prevent restenosis, restoring blood flow in lower extremity and other peripheral vascular applications.

Innovative cardiac stent designed to degrade completely within two years post-implantation, eliminating long-term foreign material presence in coronary vessels.

Biodegradable stent for intestinal anastomosis procedures that maintains luminal patency and is naturally absorbed, avoiding secondary surgical removal.

Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.

A biodegradable stent manufactured from synthesized polymers with controlled composition and molecular weight. The stent is designed for high-strength performance and is absorbed by the body after placement.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.

Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

A coronary stent system featuring biodegradable drug coating technology designed to provide controlled medication release while the polymer scaffold progressively resorbs.

Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.